FARALLON CAPITAL MANAGEMENT LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$371,998
-22.0%
2,2000.0%0.00%0.0%
Q2 2023$477,070
+19.4%
2,2000.0%0.00%0.0%
Q1 2023$399,608
-7.6%
2,2000.0%0.00%
-33.3%
Q4 2022$432,300
-97.6%
2,200
-97.2%
0.00%
-97.0%
Q3 2022$17,994,000
+42.2%
80,000
-20.0%
0.10%
+44.9%
Q2 2022$12,651,000
-71.5%
100,000
-71.4%
0.07%
-67.8%
Q1 2022$44,377,000
-38.4%
350,000
-36.4%
0.21%
-40.6%
Q4 2021$72,050,000
-15.9%
550,000
-21.4%
0.36%
-10.0%
Q3 2021$85,631,000
+19.2%
700,000
+11.1%
0.40%
+36.5%
Q2 2021$71,814,000
-11.5%
630,000
-6.7%
0.29%
-27.3%
Q1 2021$81,155,000
+14.1%
675,000
-3.6%
0.40%
-5.8%
Q4 2020$71,113,000
+31.4%
700,0000.0%0.43%
+14.4%
Q3 2020$54,124,000
-15.6%
700,000
+21.7%
0.37%
-27.1%
Q2 2020$64,090,000
+57.0%
575,000
+1.4%
0.51%
+46.6%
Q1 2020$40,827,000
-9.7%
567,047
-5.5%
0.35%
+14.8%
Q4 2019$45,204,000600,0000.30%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders